AI assistant
Sending…
Mural Oncology PLC — Director's Dealing 2023
Nov 7, 2023
14932_dirs_2023-11-07_f8bce42f-b4a9-401c-98f5-549f632041b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Mural Oncology plc (MURA)
CIK: 0001971543
Period of Report: 2023-10-31
Reporting Person: Loew Caroline (N/A)
More from Mural Oncology PLC
Major Shareholding Notification
2025
Dec 16
Regulatory Filings
2025
Dec 15
Regulatory Filings
2025
Dec 9
Regulatory Filings
2025
Dec 5
Transaction in Own Shares
2025
Dec 5
Regulatory Filings
2025
Dec 5
Capital/Financing Update
2025
Dec 5
Director's Dealing
2025
Dec 5
Director's Dealing
2025
Dec 5
Director's Dealing
2025
Dec 5